A Study to Investigate HLA-G Targeted Exosome (SOB100) in Healthy Subjects

计划入组 15 人 · 首次发布于 2025 年 10 月 22 日

A Study on the Safety, Tolerability, Pharmacokinetics, and Antitumor Activity of SKB500 in Subjects With Advanced Solid Tumors

计划入组 180 人 · 首次发布于 2024 年 12 月 16 日

A Study to Assess the Safety, Tolerability, and Efficacy of Long-term SOBI003 Treatment in Pediatric MPS IIIA Patients

计划入组 6 人 · 首次发布于 2019 年 1 月 22 日

FOL100

MB100

ADU-S100

C₂₀H₂₄N₁₀O₁₀P₂S₂

World's First HLA-G Targeted Exosome Therapy SOB100 Receives FDA Approval for Phase I Cancer Trials

Extracellular Vesicles as Next-Generation Therapeutics: Global Pipeline, Regulatory Landscape, and Translational Challenges

SOTIO's SOT106 ADC Shows Promise in Sarcoma Treatment with Strong Preclinical Results